最新ニュース Invivyd (NASDAQ:IVVD) 株価情報

INVIVYD INC

Invivyd

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Invivyd Inc

News

General

RSLS

ReShape Lifesciences Entered Into Equity Distribution Agreement Relating To Sale Of Up To $9.7M Of Shares Of Common Stock

GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) has outperformed the market over the past 5 years by 81.59% on an annualized basis producing an average annual return of 95.44%. Currently, GameStop has a market capitalization of $13.30 billion. 
Buying $100 In GME: If an investor had bought $100 of GME stock 5 years ago, it would be worth $2,886.20 today based on a price of $29.74 for GME at the time of writing.
<h3>GameStop's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748637912_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Offerings

MGRX

Mangoceuticals Files For Resale Up To 4.5M Shares Of Common Stock By Selling Shareholders

LUCD

Lucid Diagnostics May Offer Sell Shares Of Common Stock Of Up To $25M

MNSB

MainStreet Bancshares Says Determined To Report Information Related To A Data Security Incident Which It Has Been Investigating; In March 2025, Company Was Made Aware That An Outside Vendor To Core Bank Had Been Compromised; Compromised Vendor System Included 4.65% Of Customer Data

LOGC

ContextLogic To Delist From The Nasdaq; Co. Set To Begin Trading On The OTC Markets On June 3, 2025

Brag House Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBH#NASDAQ">TBH</a>), the Gen Z engagement platform at the intersection of gaming, college sports, and digital media, today announced that it continues to diligently work on its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025.
As anticipated, on May 27, 2025, the Company received notice from the Nasdaq Stock Market that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Form 10-Q. Brag House intends to file its Form 10-Q before the date it would have to submit a compliance plan on July 28 to Nasdaq for continued listing. The Nasdaq notice has no immediate effect on the listing or trading of Brag House's common stock on the Nasdaq Capital Market.

Brag House Holdings Says Working To File Delayed Q1 2025 10-Q; Receives Nasdaq Noncompliance Notice Aims To Meet July 28 Deadline

A new report of the most-viewed television series in the 2024-2025 season shows Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) and Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>) as winners across broadcast television and<a href="https://www.benzinga.com/topic/streaming"> the streaming sector.</a>
What Happened: Data from Nielsen that tracks 35 days of viewership across traditional television, cable and streaming — without including sports — shows Netflix the streaming leader and Paramount <a href="https://www.benzinga.com/general/entertainment/25/05/45363944/cbs-highlights-tv-dominance-17-year-streak-on-top-can-success-help-offset-trump-merger-concerns">the broadcast leader.</a>
Here are the top 10 most-viewed shows during the time period, as reported by <a href="https://variety.com/2025/tv/news/most-popular-tv-shows-2024-25-squid-game-adolescence-1236412566/">Variety</a>, with their average viewership.
<ol class="wp-block-list">
<li>&#8220;Squid Game,&#8221; Netflix: 27.1 million</li>
<li>&#8220;Adolescence,&#8221; Netflix: 19.0 million</li>
<li>&#8220;Tracker,&#8221; CBS: 17.4 million</li>
<li>&#8220;Reacher,&#8221; Prime Video: 17.4 million</li>
<li>&#8220;High Potential,&#8221; ABC: 16.1 million</li>
<li>&#8220;Matlock,&#8221; CBS: 16.0 million</li>
<li>&#8220;Landman,&#8221; Paramount+, 15.8 million</li>
<li>&#8220;Monsters: The Lyle and Erik Menendez Story,&#8221; Netflix: 15.7 million</li>
<li>&#8220;Zero Day,&#8221; Netflix: 15.7 million</li>
<li>&#8220;Nobody Wants This,&#8221; Netflix: 15.2 million</li>
</ol>
Netflix dominated the list with five of the top 10. The streaming giant also had numbers 11, 12, 13, 14 and 15 on the list giving it 10 of the top 15. Overall, Netflix had 12 of the top 25 series.
Paramount ranked second with three of the top 10. The company also had 16, 17 and 21 on the list, good for six of the top 25 series.
Outside of these two, Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) had "High Potential" at fifth place. The series had split viewership between ABC and Hulu, according to the report.
Prime Video from Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) had the fourth most-watched title in "Reacher." This was the only top 25 title for Amazon with its next best ranked 42nd and other hits like "Beast Games" ranking 73rd on the list, with only viewers available from streaming and not multiple platforms.
Read Also: <a href="https://www.benzinga.com/general/entertainment/25/05/45676520/is-paramount-offering-millions-to-trump-to-end-60-minutes-lawsuit-report-says-opening-offer-has-been-made">Is Paramount Offering Millions To Trump To End &#8217;60 Minutes&#8217; Lawsuit? Report Says &#8216;Opening Offer Has Been Made&#8217;</a>
Why It's Important: The rankings also show average viewership for the key age 18 to 49 demographic, which shows an even larger dominance from Netflix.
Netflix had six of the top 10 series for the 18 to 49 age demographic with "Squid Game," "Adolescence," "Monsters," "Nobody Wants This," "Running Point" and "Ms. Rachel." The streaming giant had 17 of the top 25 shows for viewership in this key age demographic.
For Paramount, the results were much different as the company only had one title rank in the top 10 for the key age demographic with "Landman." Unlike other series that air on CBS and stream on Paramount+, "Landman" is a streaming exclusive title.
Paramount's next highest title on the 18 to 49 chart is "Mobland" at 30.
This means Paramount is getting much higher viewership from its broadcast segment (CBS) than from its streaming. It also shows the balance of the company having a strong network and streaming platform with positions on both top 10 lists. This also illustrates Paramount is one of the winners in having series that appeal to all ages, including the 50+ demographic.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/entertainment/25/05/45524031/n-is-for-netflix-streamer-to-show-viewers-how-to-get-to-sesame-street">N Is For Netflix: Streamer To Show Viewers How To Get To &#8216;Sesame Street&#8217;</a></li>
</ul>
Photos: Shutterstock

Entertainment

AMZN

NFLX

PARA

PARAA

Netflix, Paramount Dominate New Top Series Viewers: How Streaming, Connection With Different Age Demographics Helps

A new study from the Society of Economic Geologists (SEG) warns that copper prices will need to more than double if the world is to produce enough of the metal to support the <a href="https://www.benzinga.com/topic/renewable-energy">global energy transition</a>.
The <a href="https://pubs.geoscienceworld.org/segweb/segdiscovery/article/doi/10.5382/SEGnews.2025-141.fea-01/654182/Copper-Mining-Development-and-Electrification">research paper</a> by Cathles, Simon and Wood reveals that current and anticipated copper production falls far short of the demands imposed by both continued global development and decarbonization efforts. These experts from Cornell University, the University of Michigan, and the University of Queensland argue that unless prices rise substantially to incentivize new mining, the energy transition will stall—crippled by a fundamental material shortfall.
Even in the "business-as-usual" demand scenario, which excludes the impacts of electrification and focuses solely on expected growth from rising global incomes and population, the mined copper output must increase from 20.4 million tons per year in 2018 to 37.1 million tons per year by 2050. Such growth would require adding over half a million tons of new capacity each year —a challenge equivalent to commissioning 36 large new mines or 759 smaller ones within just three decades.
Given that large copper mines often take more than 20 years to develop from discovery to production, the authors deem this outcome improbable. Five of the current top ten mines are expected to close by 2050, and many smaller mines <a href="https://www.benzinga.com/25/04/44682458/coppers-rout-sees-a-massive-intraday-price-swing-fundamentals-havent-changed-expert-says">will follow suit</a>.
However, mining economics notably worsen the picture. The rising development cost means that brownfield projects now require around $23,000 per ton of added annual production capacity. Since copper prices generally track capital intensity one-to-one, the authors conclude that "the future copper price must exceed $20,000 per ton" to make new development viable. At today's price of roughly $9,600, that means copper prices must more than double just to enable supply to meet projected demand.
Yet, those problems seem minuscule in comparison to supply problems when considering electrification and energy transition, especially the demand from wind and solar energy generation. If those two sources of energy were to dominate the power mix, annual copper mining would have to increase by 22.5 large new mines per year on average between 2018 and 2035.
"Deposits cannot be discovered and mines cannot be developed at this rate," the authors noted. In this scenario, more copper would be mined by 2050 than in all previous human history combined, with over half of the known copper endowment exhausted in just three decades.
The International Energy Agency <a href="https://www.iea.org/news/ai-is-set-to-drive-surging-electricity-demand-from-data-centres-while-offering-the-potential-to-transform-how-the-energy-sector-works">report</a> warns that the world is closer to the second scenario than the first one. According to the latest research, global electricity use from AI data centers is expected to more than double by 2030, reaching approximately 945 terawatt-hours (TWh), surpassing the current power consumption of Japan. With the rise of AI, demand for clean, reliable electricity is skyrocketing. Yet building solar- and wind-heavy grids capable of supporting AI's loads would significantly increase the need for copper-intensive grid infrastructure and storage.
The SEG study also highlights a global equity issue. Developing countries require approximately 1,043 million tons of copper to achieve infrastructure levels comparable to those in high-income nations. That is equivalent to 50 years of current global copper production. Thus, a copper shortage problem and a price bidding war could result in resource hoarding, diverting the metal away from the developing world's growth.
"Society can have a win-win solution or a fail-fail solution. For a win-win outcome, the copper needs of the electrical transition must be nearly completely eliminated," the research said.
To ensure copper is available for both electrification and human development, strategies that minimize copper use, such as nuclear power, methane backup plants, and hybrid vehicles, must be a priority, scientists concluded.
Price Watch: iShares Copper and Metals Mining ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICOP#NASDAQ">ICOP</a>) is up 9.52% year-to-date.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/rumors/25/05/45693244/glencores-restructuring-sets-stage-for-mining-mega-merger">Glencore&#8217;s Restructuring Sets Stage For Mining Mega-Merger</a></li>
</ul>
Photo by TimBrew via Shutterstock.

Commodities

ICOP

Energy Goals Are Impossible Without Copper Price Surge, Study Shows

<a href="https://www.cnbc.com/halftime/" title="https://www.cnbc.com/halftime/">https://www.cnbc.com/halftime/</a>

UPDATE: Today On CNBC Halftime Report, Josh Brown Changed Final Trade From Netflix To JP Morgan Chase & Co.

9F Inc Receives Nasdaq Letter Regarding Late Filing of Form 20-F

Buybacks

REAX

Real Brokerage Board Authorizes New Share Repurchase Program For Up To Lesser Of $150M In Value, Or 35M In Shares

Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) has outperformed the market over the past 5 years by 276.89% on an annualized basis producing an average annual return of 290.74%. Currently, Quest Diagnostics has a market capitalization of $19.32 billion. 
Buying $1000 In DGX: If an investor had bought $1000 of DGX stock 5 years ago, it would be worth $1,019,647.06 today based on a price of $173.07 for DGX at the time of writing.
<h3>Quest Diagnostics's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748637015_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 22.08% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 19.73% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 13.64% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 9.67% at $0.48</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 6.06% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 5.77% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 4.14% at $1.79</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 3.54% at $7.42</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.25% at $0.28</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 50.00% at $0.0002</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 22.81% at $1.32</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 11.29% at $0.60</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 8.49% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 7.15% at $0.43</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 5.88% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 5.36% at $0.83</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 3.27% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed down 3.08% at $1.27</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 3.07% at $4.00</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

CLSH

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CVSI

FFNTF

ITHUF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LVRLF

NWVCF

OILFF

RMHB

SNDL

SOLCF

TCNNF

TGIFF

TLRY

ZDPY

Marijuana Stock Movers For May 30, 2025

Haoxi Health Technology Files For Mixed Shelf Of Up To $80M

A gauge tracking the so-called &#8220;magnificent seven&#8221; — which includes Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>), Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>). Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) — surged 15% in May.
The rally coincided with an especially solid month for U.S. equities. The S&amp;P 500, tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), surged more than 6% for the month. That&#8217;s its strongest month since November 2023.
But beneath the surface <a href="https://www.benzinga.com/general/education/25/05/45675595/apple-eyes-worst-month-vs-sp-500-since-2018-but-history-says-buy-the-dip-now#:~:text=Apple%2520underperformed%2520S%2526P%2520500%2520by,expert%2520insights%2520for%252060%2525%2520off.">is Apple's rare underperformance.</a>
Six out of the magnificent seven tech giants logged monthly gains. The iPhone maker, however, lagged its peers and delivered its weakest relative performance against the S&amp;P 500 Index since 2018.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-1024x535.png" alt="" class="wp-image-933762" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-1536x803.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30154913/image-426-2048x1070.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In contrast, Nvidia posted a staggering 24% monthly jump — its best performance since May 2024 — after delivering <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45668727/nvidia-stock-is-surging-thursday-whats-fueling-the-move">better-than-expected quarterly earnings.</a>
Despite facing export restrictions on its chips to China, Nvidia's revenue resilience confirmed that artificial <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45675006/nvidia-stock-has-significant-upside-as-ai-godfather-jensen-huang-delivers-another-robust-quarter">intelligence demand remains healthy.</a> Overall revenue reached $44.1 billion, up 69% from a year ago.
"Countries around the world are recognizing AI as essential infrastructure — just like electricity and the internet — and Nvidia stands at the center of this profound transformation," CEO Jensen Huang said.
While Wall Street paints a positive picture, Main Street tells a different story, as pessimism among U.S. consumers runs high.
The U.S. economy contracted by 0.2% <a href="https://www.benzinga.com/government/regulations/25/05/45669445/us-economy-contracts-by-02-in-q1-labor-market-shows-signs-of-cracks-as-jobless-claims-surge">in the first quarter</a>, a slight upward revision from the initial -0.3% estimate, yet a stark reversal from the 2.4% growth rate seen in late 2024. Inflation, as measured by the <a href="https://www.benzinga.com/cannabis/25/05/45693219/feds-favorite-inflation-gauge-slows-but-trumps-china-accusation-flips-market-mood">Personal Consumption Expenditures price index</a>, cooled to 2.1% in April — its lowest pace in six months — from 2.3% in March.
But the public doesn&#8217;t seem to trust the disinflation narrative.
According to the University of Michigan's May survey, Americans expect inflation to run at 6.6% over the next year, <a href="https://www.benzinga.com/markets/economic-data/25/05/45697983/consumer-sentiment-stuck-at-3-year-lows-as-inflation-fears-hit-44-year-high">the highest level since 1981</a>. That figure reflects the widest gap ever recorded between perceived and actual inflation. Meanwhile, overall sentiment remains near three-year lows.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-1024x535.png" alt="" class="wp-image-933763" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-1536x803.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30155117/image-427-2048x1070.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In a notable development on the trade front, the U.S. Court of International Trade struck down significant portions of President Donald Trump's newly proposed tariff actions.
While the move sparked brief investor optimism, analysts caution the Trump administration retains various legal avenues to <a href="https://www.benzinga.com/government/regulations/25/05/45672421/tariffs-blocked-by-court-but-goldman-sachs-says-trump-could-reimpose-them-within-days">reintroduce similar trade barriers.</a>
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/05/45703175/netflix-stock-could-climb-another-25-thanks-to-second-half-content-bonanza-says-bank-of-america">Netflix Stock Could Climb Another 25% Thanks To Second-Half &#8216;Content Bonanza,&#8217; Says Bank Of America </a></li>
</ul>
Image: Shutterstock

Tech

AAPL

GOOGL

MSFT

NVDA

TSLA

Magnificent Seven Drive Wall Street's Rally, Nvidia Notches Best Month In A Year: This Week In Markets

Meta Platforms Shareholders Reject Dual Class Capital Structure Proposal

Eversource Energy Enters Equity Distribution Agreement With Multiple Manager; To Issue And Sell Shares Up To $1.2B

On May 29, 2025, D-Wave Quantum Inc. (the "Company") received proceeds in the aggregate amount of approximately $80.5 million in connection with the exercise of approximately 7.0 million warrants to purchase shares of the Company's common stock with an exercise price of $11.50 per warrant. These warrants were assumed by the Company in conjunction with the August 5, 2022 merger with DPCM Capital, Inc.

QBTS

D-Wave Quantum Receives ~$80.5M from Exercise Of 7M Warrants At $11.50 Each, Originating From 2022 Merger With DPCM Capital

Modiv Industrial Files For Mixed Shelf Of Up to $250M

Management

Press Releases

Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors

Financing

Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank

Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025

Health Care

Invivyd Announces New Pipeline Discovery Program Focused on Monoclonal Antibody Treatment for Measles

Invivyd to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Invivyd Files Citizen Petition Urging FDA to Focus on Monoclonal Antibodies For Endemic-Virus-Era COVID-19 Prevention, and to Re-Assess COVID-19 Vaccine Efficacy

Earnings

Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights

Invivyd Commends FDA Focus on Contemporary Evidence In Evaluating Medical Interventions To Prevent COVID-19

Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas

Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Population Against Relevant, Immune-Evasive SARS-CoV-2 Virus

Comments

Invivyd

ニュース

最新ニュース Invivyd (NASDAQ:IVVD) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル